Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide is a synthetic small molecule compound with the molecular formula C18H14IN3O3 and a molecular weight of approximately 447.23 g/mol[1][5][6]. It belongs to the class of organic compounds known as anilides, which are derivatives of oxoacids containing an amide group attached to an aromatic ring[2]. The compound is listed in several chemical and drug databases under code names such as DB07039 and 3B6, but there is no evidence it has been approved for any therapeutic use or entered clinical trials beyond preclinical or experimental stages[1][2]. Its mechanism of action, biological targets, pharmacological activity, and potential indications have not been described in publicly available sources. There are no known brand names or marketed formulations.
- Other names
- (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
Beyond the preview
Go deeper on (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide.